Also trades as: 0J4V.L (LSE) · $vol 0M
HRTX NASDAQ
Heron Therapeutics, Inc.
1W: +18.1%
1M: +11.1%
3M: -19.9%
YTD: -72.4%
1Y: -72.2%
3Y: -64.9%
5Y: -97.2%
$0.35
-0.01 (-2.33%)
Weekly Expected Move ±12.2%
$0
$0
$0
$0
$0
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$151M
Revenue
+1.0% YoY
$-34M
Net Income
-3557.3% YoY
$-12M
Free Cash Flow
+58.9% YoY
69.3%
Gross Margin
-5.4%
Op. Margin
-14.6%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE334.6%
ROA-14.1%
ROIC-7.6%
Valuation
P/E-1.9
P/B9.6
EV/EBITDA-6.7
Leverage
Debt/Equity21.48
Current Ratio2.49
Interest Cov.-7.7x
Quality Scores
Piotroski F3/9
Altman Z-9.78
Beneish M-2.82